News & Resources

Distributing Information on New Clinical Trials: How to Effectively Share Key Data

Each year, the medical industry uncovers exciting new data that can help in the fight against cancer. However, this information isn’t always distributed effectively. Yet stakeholders desperately need access to the latest clinical data. If they aren’t able to locate these data, patients may not benefit from the new insights.

Information gaps have a tremendous effect both on medical providers and patients. Without up-to-date information about new clinical trials, oncologists may not be able to make optimal treatment decisions. Their patients may be unable to fully advocate for themselves if they don’t have access to data that support their treatment preferences.

Pharmaceutical companies must ensure relevant clinical data are accessible both to laypeople and healthcare providers. When each staff member at a pharmaceutical company has access to the same data, clients and patients receive consistent responses. Once everyone is equipped with accurate data, patient treatment can benefit. To effectively distribute clinical data, consider the following strategies:

Maintain a Professional, Up-to-Date Internet Presence
In the 21st century, having a strong internet presence is not optional. Most laypeople are suspicious of organizations without a website. At best, these organizations may be seen as unprofessional. At worst, they may seem risky or even dishonest. An established organization must have a professionally-managed website.

However, the expectations for healthcare providers and patients don’t end there. Website visitors also expect up-to-date social media accounts. Pharmaceutical companies who fail to meet these expectations are also missing out on opportunities to share essential data.

This type of outreach and marketing is easier in some regions than others. Pharmaceutical companies in the US can reach out directly to patients, providing clinical data and information about newly approved treatments. This may not be possible in Europe and Canada. But even in countries where companies are not permitted to contact patients directly, a high-quality Web presence can help organizations stay in the public eye.

Websites should at minimum include mission statements and descriptions of the company’s various departments, and might also include general information about how clinical studies are performed. A company website is also an excellent place to feature photos of key clinical staff. This builds interest and trust in the organization. Healthcare providers may then feel inclined to reach out to these companies, and find ways to access their clinical data.

Invest in Social Media
Social media is invaluable for quickly distributing information. There’s no question that both healthcare providers and laypeople are eager to learn about the latest medical advances. However, locating reliable studies and useful case reports can be a challenge.

Leveraging a company’s social media accounts allows US companies to distribute clinical data as soon as they are available. Since many people check their social media a dozen times a day, life science organizations serving the US have countless opportunities to get their message in front of a curious audience.

A social media manager can also help develop a targeted strategy to build an audience and tailor a message to meet its needs. As with all forms of outreach and marketing, consistency is vital. Delivering a steady stream of content helps life science organizations establish themselves as an active, trustworthy source of information.

Launch a Blog
While social media can be an excellent tool for sharing information quickly, it doesn’t always allow for long-form content. Merely tweeting a link to a new medical study may not be enough to get the message across. This is where blogs come in.

A blog can be the ideal place to dig deeper into the implications of new clinical data. Blog posts provide space to review recent studies, discuss the results, and offer practical tips to clinicians looking to apply these data.

In Europe and Canada, where restrictions on clinical data may apply, companies can still use their blog to reach out to medical providers. Password-protected Web spaces help ensure that essential information is available to clinicians, while avoiding direct communication with patients. Trusted healthcare providers then have the information they need to start conversations with their patients.

When developing a blogging strategy, it’s essential to keep readability in mind. Reaching out to healthcare providers may be a priority, but many laypeople are also interested in learning about new clinical data. These individuals can help carry important messages to a broader community. Companies targeting US audiences must make sure to deliver blog content that can be easily understood by patients and their families.

Cite Sources on Informational Materials
Unfortunately, the internet isn’t always a source of reliable information. Social media and blogs are often used to spread myths and false data. Pharmaceutical companies can fight this trend by citing sources in their social media and blog posts. Diligent citation sends a strong impression to viewers. Educated viewers learn to see these organizations as a source of high-quality information.

Citing sources on printed information, such as brochures and pamphlets, can also be a valuable marketing tool. Many pharmaceutical companies in the US make bold claims on their marketing or promotional materials, and patients may rightfully be skeptical. Providing the right citations proves to viewers the latest research supports these claims. Leveraging printed materials as a means of distribution also helps companies reach individuals who don’t spend much time online.

Outsource Writing, Blogging, or Social Media
Many pharmaceutical companies put off setting up their social media accounts. Others start a blog but seldom update it. Inconsistent posting can keep an organization from gaining readers and followers. However, many organizations struggle to find time for these initiatives.

Using a content-writing service or social media management company allows organizations to outsource these tasks. These companies provide expert blogging and social media services, which takes the pressure off full-time employees within a pharmaceutical company. Hiring outside workers also helps bring fresh ideas and approaches. Professional writers or bloggers can then work with pharmaceutical companies to gather and redistribute exciting new information.

For organizations in Europe and Canada, it may be helpful to hire an organization that specializes in medical marketing within these regions. While many US-based organizations provide skilled writing or social media services, they might be unaware of regional restrictions that limit marketing or outreach efforts. A European-based company can provide added expertise.

Test Online Forums
Years ago, clinicians gained most of their information from medical textbooks and in-person conferences. Today, the internet is the average clinicians’ primary source of new medical knowledge. Many clinicians think nothing of pulling out their phone and performing an on-the-spot Web search while seeing a patient. Pharmaceutical companies must consistently find ways to connect with healthcare providers using technology.

Online forums are a popular tool for finding groups of people with similar interests. After a cancer diagnosis, patients often gravitate toward forums designed for individuals living with cancer. In turn, oncologists are always on the hunt for a way to connect with colleagues remotely. Forums for clinicians to discuss research and treatment strategies are often appealing to these providers.

Community Access Scientific Exchange Series by Aptitude Health, also known as CASES, helps meet the demand for high-quality forums. CASES provides a valuable tool both for oncologists and pharmaceutical companies to share essential data.

CASES by Aptitude Health
Today’s oncologists have limited time for attending conferences or in-person meetings. CASES allows these providers to fit meaningful discussions into a tight schedule. The discussion board lets clinicians share information with their colleagues. Participants can share their thoughts in a secure environment filled with people they can trust.

Pharmaceutical companies can also use CASES to bridge the gap between their industry, and community oncologists. With CASES, organizations can highlight current research, gather information about regional trends, and better understand what factors drive treatment decisions.

Armed with this information, companies can work with oncologists and other stakeholders helping to defeat cancer.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.